INSANE: Thermo fisher scientific | Rare Historical Photos

Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built

Biotech stocks trade on FDA trial phases. Phase 2 data often builds value, cash runway limits dilution, and Quantum BioPharma just began a phase 2 MS trial.

MarketBeat · 11h ago

Thermo Fisher Scientific's Q3 2026 Earnings: What to Expect

Thermo Fisher Scientific is poised to release its third-quarter results later this month, and analysts project a double-digit earnings rise.

Barchart · Oct 9

Is Thermo Fisher Scientific Stock Outperforming the Nasdaq?

Thermo Fisher Scientific has outperformed the Nasdaq over the past year, yet Wall Street analysts remain bullish on the stock, reflecting confidence that its strong growth trajectory has further room to run.

Barchart · Aug 31

Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets

Hedge fund billionaire Daniel Loeb reduced its exposure to life Sciences Tools & Services sector by cutting stake in Danaher Corporation (NYSE:DHR) and fully exiting position in Thermo Fisher Scientific Inc (NYSE:TMO) in the first quarter of 2026.

Benzinga · Jul 24

Is Thermo Fisher Scientific Stock Underperforming the S&P 500?

Despite Thermo Fisher Scientific's underperformance relative to the SPX over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart · May 29

Thermo Fisher Teams Up With UK Firm To Scale Genetic Heart Disease Screening

UK-based GENinCode PLC unveiled a wide-ranging commercial partnership with Thermo Fisher Scientific Inc (NYSE:TMO) to manufacture, sell, and distribute its CARDIO inCode-Score test.

Benzinga · Dec 4, 2025

Thermo Fisher Scientific Stock: Is TMO Outperforming the Health Care Sector?

Thermo Fisher Scientific has outperformed the broader healthcare sector over the past year, and analysts continue to hold a strongly bullish view on its growth prospects.

Barchart · Nov 26, 2025

Thermo Fisher To Acquire Clario Holdings For $8.875 Billion, Expands Digital Pharma Capabilities

Thermo Fisher Scientific (NYSE:TMO) shares are trading higher on Wednesday after the company inked a deal to acquire Clario Holdings for $8.875 billion in cash, plus potential future earnout and other performance-based payments.

Benzinga · Oct 29, 2025

Thermo Fisher Scientific Analysts Increase Their Forecasts After Upbeat Q3 Earnings

Thermo Fisher Scientific Inc (NYSE:TMO) reported better-than-expected earnings for the third quarter on Wednesday.

Benzinga · Oct 23, 2025

Thermo Fisher's Upbeat Earnings Suggest Worst Is Over For Scientific Tools Sector, Analyst Says

Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday reported third-quarter 2025 adjusted earnings of $5.79 per share, beating the street view of $5.49.

Benzinga · Oct 22, 2025